Trace Elements in Children With Pre-Dialysis and End-Stage Renal Disease
Abstract
Background/Aim: Chronic kidney disease (CKD) impacts 11-13 % of world wild population and can lead to end-stage renal disease (ESRD). Paediatric CKD is connected with considerable morbidity and necessity for early management. Trace elements as iron (Fe), zinc (Zn) and copper (Cu) are required for a variety of physiological activities and may influence CKD progression. The main goal of this work was to analyse the amounts of trace elements among children with CKD and ESRD and their potential as disease stage biomarkers.
Methods: The study comprised 40 pre-dialysis CKD patients, 40 dialysis-dependent ESRD patients and 40 healthy controls aged 0 to 19 years. Blood samples were obtained and tested for Fe, Zn and Cu levels utilising flame-atomic absorption spectrophotometry (FAAS). Anthropometric data, such as age, body mass index (BMI) and blood pressure, were also collected. The statistical calculations were done by the utilising of SPSS version 25.0.
Results: Trace element levels varied significantly between groups. Cu levels were higher, while Fe and Zn concentrations were lower in CKD and patients on dialysis compared to controls, with Zn exhibiting the greatest drop. Zn had the highest accuracy as a biomarker for CKD and ESRD, with an AUC of 0.999, sensitivity of 100 % and specificity of 98 %.
Conclusion: Zn is a promising biomarker for detecting CKD development and distinguishing between CKD stages and ESRD. Regular trace element monitoring is critical for controlling paediatric chronic kidney disease and improving patients’ consequences. Further research is needed to determine the therapeutic potential of trace element management in CKD.
References
Tegegne B, Demeke T, Amme S, Edmealem A, Ademe S. Knowledge towards prevention and early detection of chronic kidney disease and associated factors among hypertensive patients at a chronic illness Clinic of Jimma Town Public Hospitals. BioMed Res Int. 2020;2020(1):5969326. doi: 10.1155/2020/5969326.
Wouk N. End-stage renal disease: medical management. Am Family Phys. 2021;104(5):493-9. PMID: 34783494.
Santos-Araújo C, Mendonça L, Carvalho DS, Bernardo F, Pardal M, Couceiro J, et al. Twenty years of real-world data to estimate chronic kidney disease prevalence and staging in an unselected population. Clin Kidney J. 2023;16(1):111-24. doi: 10.1093/ckj/sfac206.
Groothoff JW. Long-term outcome of kidney failure in children. In: Pediatric Kidney Disease. Berlin: Springer; 2023. pp. 1937-62. doi: 10.1007/978-3-031-11665-0_70.
Stern-Zimmer M, Calderon-Margalit R, Skorecki K, Vivante A. Childhood risk factors for adulthood chronic kidney disease. Pediatric Nephrol. 2021;36(6):1387-96. doi: 10.1007/s00467-020-04611-6.
Chevalier RL. CAKUT: a pediatric and evolutionary perspective on the leading cause of CKD in childhood. Pediatric Reports. 2023;15(1):143-53. doi: 10.3390/pediatric15010012.
Staley BS. Population-based study of plasma metabolites as mediators of the relationship between socioeconomic status and incident diabetes: a social metabolomic approach to health disparities. Chapel Hill, NC: The University of North Carolina at Chapel Hill; 2023.
Thumfart J, Wagner S, Kirchner M, Azukaitis K, Bayazit AK, Obrycki L, et al. Timing and modality of kidney replacement therapy in children and adolescents. Kidney Int Reports. 2024. doi: 10.1016/j.ekir.2024.06.009.
Abdullah S, Methven S, Tomson CR. Clinical Management of CKD: Prevention of progression. In: Primer on nephrology. Berlin, Germany: Springer; 2022. pp. 1149-61. doi: 10.1007/978-3-030-76419-7_67.
Bello AK, Okpechi IG, Osman MA, Cho Y, Htay H, Jha V, et al. Epidemiology of haemodialysis outcomes. Nature Rev Nephrol. 2022;18(6):378-95. doi: 10.1038/s41581-022-00542-7.
De Clerck D, Bonkain F, Cools W, Van der Niepen P. Vascular access type and mortality in haemodialysis: a retrospective cohort study. BMC Nephrol. 2020;21:1-7. doi: 10.1186/s12882-020-01889-4.
Islam MR, Akash S, Jony MH, Alam MN, Nowrin FT, Rahman MM, et al. Exploring the potential function of trace elements in human health: a therapeutic perspective. Mol Cellular Biochem. 2023;478(10):2141-71. doi: 10.1007/s11010-022-04638-3.
Filler G, Qiu Y, Kaskel F, McIntyre CW. Principles responsible for trace element concentrations in chronic kidney disease. Clinical Nephrol. 2021;96(1):1. doi: 10.5414/CN110322.
Taha Mohammed M. Investigation of immunological parameters IL-27 and IL-35 and electrolyte sodium, potassium, and calcium in the sera of rheumatoid arthritis females. Egyptian J Chem. 2023;66(4):147-50. doi: 10.21608/ejchem.2022.141260.6177.
Mahdi MA, Mohammed MT, Jassim AMN, Mohammed AI. Phytochemical content and anti-oxidant activity of Hylocereus undatus and study of toxicity and the ability of wound treatment. Plant Arch. 2018;18(0972-5210):2672-80.
Dawood YJ, Mahdi MA, Jumaa AH, Saad R, Khadim RM. Evaluation of LH, FSH, oestradiol, prolactin and tumour markers CEA and CA-125 in sera of Iraqi patients with endometrial cancer. Scr Med. 2024;55(4):419-26. doi: 10.5937/scriptamed55-49925.
Staples AO, Greenbaum LA, Smith JM, Gipson DS, Filler G, Warady BA, et al. Association between clinical risk factors and progression of chronic kidney disease in children. Clin J Am Soc Nephrol. 2010;5(12):2172-9. doi: 10.2215/CJN.07851109.
Warady BA, Chadha V. Chronic kidney disease in children: the global perspective. Pediatric Nephrol. 2007;22(12):1999-2009. doi: 10.1007/s00467-006-0410-1.
Stenvinkel P, Zoccali C, Ikizler TA. Obesity in CKD—what should nephrologists know? J Am Soc Nephrol. 2013;24(11):1727-36. doi: 10.1681/ASN.2013040330.
Mitsnefes M, Ho P-L, McEnery PT. Hypertension and progression of chronic renal insufficiency in children: a report of the North American Pediatric Renal Transplant Cooperative Study (NAPRTCS). J Am Soc Nephrol. 2003;14(10):2618-22. doi: 10.1097/01.ASN.0000089565.04535.4B.
Hsu CN, Tain YL. Targeting the renin–angiotensin–aldosterone system to prevent hypertension and kidney disease of developmental origins. Int J Molecular Sci. 2021;22(5):2298. doi: 10.3390/ijms22052298.
Becherucci F, Roperto RM, Materassi M, Romagnani P. Chronic kidney disease in children. Clin Kidney J. 2016;9(4):583-91. doi: 10.1093/ckj/sfw047.
Flynn JT, Mitsnefes M, Pierce C, Cole SR, Parekh RS, Furth SL, et al. Blood pressure in children with chronic kidney disease: a report from the Chronic Kidney Disease in Children study. Hypertension. 2008;52(4):631-7 doi: 10.1161/HYPERTENSIONAHA.108.110635.
Rolić T, Yazdani M, Mandić S, Distante S. Iron metabolism, calcium, magnesium and trace elements: a review. Biol Trace Element Res. 2024:1-10. doi: 10.1007/s12011-024-04289-z.
Batchelor EK, Kapitsinou P, Pergola PE, Kovesdy CP, Jalal DI. Iron Deficiency in Chronic Kidney Disease: Updates on Pathophysiology, Diagnosis, and Treatment. J Am Soc Nephrol. 2020;31(3):456-68. doi: 10.1681/ASN.2019020213.
Stauffer ME, Fan T. Prevalence of anemia in chronic kidney disease in the United States. PloS One. 2014;9(1):e84943. doi: 10.1371/journal.pone.0084943.
Pasricha S-R, Tye-Din J, Muckenthaler MU, Swinkels DW. Iron deficiency. Lancet. 2021;397(10270):233-48. doi: 10.1016/S0140-6736(20)32594-0.
Tang M, Zhu C, Yan T, Zhou Y, Lv Q, Chuan J. Safe and effective treatment for anemic patients with chronic kidney disease: an updated systematic review and meta-analysis on roxadustat. Frontiers Pharm. 2021;12:658079. doi: 10.3389/fphar.2021.658079.
Hain D, Bednarski D, Cahill M, Dix A, Foote B, Haras MS, et al. Iron-deficiency anemia in CKD: a narrative review for the kidney care team. Kidney Med. 2023;5(8):100677. doi: 10.1016/j.xkme.2023.100677.
Li X-Y, Ying J, Li J-H, Zhu S-L, Li J, Pai P. Growth differentiation factor GDF-15 does not influence iron metabolism in stable chronic haemodialysis patients. Ann Clin Bioch. 2015;52(3):399-403. doi: 10.1177/0004563214552109.
Abdollahi A, Ghahramani A, Ghahramani N. Zinc and kidney disease: a review. Iran J Kidney Dis. 2022;16(2):79. doi: 10.52547/ijkd.6702.
Elgenidy A, Amin MA, Awad AK, Husain-Syed F, Aly MG. Serum zinc levels in chronic kidney disease patients, hemodialysis patients, and healthy controls: systematic review and meta-analysis. J Renal Nutr. 2023;33(1):103-15. doi: 10.1053/j.jrn.2022.04.004.
Stojsavljević A, Ristić-Medić D, Krstić Đ, Rovčanin B, Radjen S, Terzić B, et al. Circulatory imbalance of essential and toxic trace elements in pre-dialysis and hemodialysis patients. Biol Trace Element Res. 2022:1-9. doi: 10.1007/s12011-021-02940-7.
Damianaki K, Lourenco JM, Braconnier P, Ghobril J-P, Devuyst O, Burnier M, et al. Renal handling of zinc in chronic kidney disease patients and the role of circulating zinc levels in renal function decline. Nephrology Dialysis Transpl. 2020;35(7):1163-70. doi: 10.1093/ndt/gfz065.
Escobedo-Monge MF, Torres-Hinojal MC, Barrado E, Escobedo-Monge MA, Marugán-Miguelsanz JM. Zinc nutritional status in a series of children with chronic diseases: a cross-sectional study. Nutrients. 2021;13(4):1121. doi: 10.3390/nu13041121.
Jäger S, Cabral M, Kopp JF, Hoffmann P, Ng E, Whitfield JB, et al. Blood copper and risk of cardiometabolic diseases: a Mendelian randomization study. Human Molecular Genetics. 2022;31(5):783-91. doi: 10.1093/hmg/ddab275.
Xu G, Hu B, Chen G, Yu X, Luo J, Lv J, et al. Analysis of blood trace elements and biochemical indexes levels in severe craniocerebral trauma adults with Glasgow Coma Scale and injury severity score. Biol Trace Element Res. 2015;164:192-7. doi: 10.1007/s12011-014-0225-z.
Abdulqader MS. Evaluation of Heavy Metals (Lead and Cadmium) and trace elements (Copper and Zinc) levels in a sample of chronic kidney disease patients undergoing hemodialysis in Kirkuk Governorate: case control study. Baghdad, Iraq: University of Baghdad; 2022.
Ortega-Romero M, Rojas-Lima E, Rubio-Gutiérrez JC, Aztatzi-Aguilar OG, Narváez-Morales J, Esparza-García M, et al. Associations among environmental exposure to trace elements and biomarkers of early kidney damage in the pediatric population. Biometals. 2024:1-17. doi: 10.1007/s10534-024-00603-3.
Ahmad S, Ärnlöv J, Larsson SC. Genetically predicted circulating copper and risk of chronic kidney disease: a mendelian randomization study. Nutrients. 2022;14(3):509. doi: 10.3390/nu14030509.
Shahreza FD. Oxidative stress, free radicals, kidney disease and plant antioxidants. Immunopathologia Persa. 2016;3(2):e11. doi: 10.15171/ipp.2017.03.
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).